Dentsply (XRAY) downgraded at UBS to Sell from Neutral, UBS said. $35 price target. Recent negative datapoints from Nobel and Align.
STOCK COMMENTS / EPS CHANGESAir Products (APD) target lowered at Jefferies to $94, Jefferies said. Shares will be range- bound into spring. Buy rating.
City National (CYN) numbers raised at BMO. Shares of CYN now seen reaching $53, according to BMO Capital. Estimates also increased, as the company is seeing higher fee income. Market Perform rating.
Edwards Lifesciences (EW - Get Report) numbers reduced at Credit Suisse. Shares of EW now seen reaching $96, according to Credit Suisse. Estimates also cut, given lower TAVI expectations. Neutral rating.
Edwards Lifesciences numbers lowered at Jefferies. Shares of EW now seen reaching $100, Jefferies said. Estimates also lowered on near- term challenges. Buy rating.Hain Celestial (HAIN) numbers raised at Canaccord. Shares of HAIN now seen reaching $66, according to Canaccord. Estimates also increased, given the recent acquisition. Buy rating. Honeywell International (HON) target raised at Oppenheimer to $71, Oppenheimer said. Operating momentum greases multiple potential. Outperform rating. Kroger (KR) estimates, target raised at Goldman. Shares of KR now seen reaching $23, according to Goldman Sachs. Estimates also increased, given higher realized growth trends. Sell rating. Manpower (MAN) estimates, target boosted at Credit Suisse. Shares of MAN now seen reaching $46, according to Credit Suisse. Estimates also upped, as higher sales are boosting margins. Outperform rating. McDonald's (MCD) estimates, target cut at Lazard. Shares of MCD now seen reaching $101, according to Lazard. Estimates also reduced, as the company is facing increased competition. Buy rating. Parker Hannifin (PH) numbers cut at Credit Suisse. Shares of PH now seen reaching $87, according to Credit Suisse. Estimates also reduced, given the company's new guidance. Outperform rating. Polaris (PII) estimates, target boosted at BMO. Shares of PII now seen reaching $105, according to BMO Capital. Estimates also upped, given the company's sales momentum. Outperform rating. Schlumberger (SLB) estimates, target increased at Guggenheim. SLB estimates were raised through 2013, Guggenheim said. Deepwater exploration demand remains strong. Buy rating and new $90 price target. Valmont (VMI) estimates, target upped at DA Davidson. VMI estimates were boosted through 2013, DA Davidson said. Company has solid business visibility. Buy rating and new $160 price target. >To submit a news tip, email: firstname.lastname@example.org.
Twitter and become a fan on Facebook.